SCHEMBL28815215

SCHEMBL28815215

COc1cnc(CSc2nc3cc(OCC(F)(F)F)ccc3[nH]2)cc1OC.COc1cnc(C[S+]([O-])c2nc3cc(OCC(F)(F)F)ccc3[nH]2)cc1OC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOS2 P35228 3/20 0.40
NOS3 P29474 2/20 0.40
NOS1 P29475 2/20 0.40
CYP2D6 P10635 7/20 0.39
CYP2C9 P11712 7/20 0.39
CYP2C19 P33261 7/20 0.39
CYP1A2 P05177 6/20 0.39
CYP3A4 P08684 6/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
ENPP1 P22413 3/20 0.38
CYP2E1 P05181 6/20 0.37
CYP2C8 P10632 6/20 0.37
CYP2B6 P20813 6/20 0.37
ATP4A P20648 3/20 0.36
ATP4B P51164 3/20 0.36
ATP1A1 P05023 2/20 0.36
ATP1B1 P05026 2/20 0.36
ATP1A3 P13637 2/20 0.36
ATP1B2 P14415 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3537809 0.91 ATP4A (0.41) CYP2C9CYP2C19CYP1A2ENPP1ATP4A
SCHEMBL3540790 0.91 NOS2 (0.47) NOS2NOS3NOS1CYP2D6CYP2C9
SCHEMBL16210742 0.87 ATP4A (0.46) NOS2NOS3NOS1CYP2D6CYP2C9
SCHEMBL9527234 0.84 ATP4A (0.42) CYP2C9CYP1A2ENPP1ATP4AATP4B
SCHEMBL9527455 0.83 CYP2D6 (0.46) NOS2NOS3NOS1CYP2D6CYP2C9
SCHEMBL10370234 0.83 ATP4A (0.38) ATP4AATP4BATP1A1ATP1B1ATP1A3
SCHEMBL10372859 0.83 ATP4A (0.38) ATP4AATP4BATP1A1ATP1B1ATP1A3
SCHEMBL10372856 0.82 CYP2D6 (0.49) NOS2NOS3NOS1CYP2D6CYP2C9
SCHEMBL10370872 0.82 CYP2D6 (0.49) NOS2NOS3NOS1CYP2D6CYP2C9
SCHEMBL6482588 0.81 ATP4A (0.44) ATP4AATP4BATP1A1ATP1B1ATP1A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104114169-A Combination of CRTH2 antagonist and a proton pump inhibitor for the treatment of eosinophilic esophagitis ATOPIX THERAPEUTICS LTD 2014-10-22 CN disclosed